Epilepsy is a chronic, neurological disorder, which has been around for 3000 years, and causes unprovoked, recurrent seizures with impacts ranging from social stigma, isolation, injury, and sudden death.
People with Epilepsy Worldwide
People with Epilepsy in the USA
New Cases Annually in the USA
Physicians rely on self reported seizure data to manage their patient's epilepsy - particularly in determining the right medication and the right dose. However, studies have shown that this data is up to 50% in accurate.
A recent study showed that in the USA, direct costs related to Epilepsy have almost doubled in the last decade to $28B per year, while outcomes have not improved in almost three decades.
Using passive oculometric data from consumer grade eye-tracking systems, our software algorithms has the potential to reliably detect seizures and other neurological 'vital signs'. By employing machine learning capabilities, we expect our software to be able to predict when a seizure will occur.
By helping physicians get the data they need to make timely medical decisions.
Getting patients on path to seizure freedom quicker and reducing the burden of tracking seizures.
Helping providers and patients reduce the number of costly visits to the hospital.
We recently completed a 30 patient proof-of-concept study which resulted in robust seizure detection of the subtlest seizure type, absence seizures.
We are currently preparing for a more in depth clinical study involving several clinical collaborators.
Neurologist with dual certification in epilepsy and neurology with over 10 years’ experience directing the clinical epilepsy and research programs at UCSF Benioff Children’s Hospital, Oakland
Leads the algorithm development for Eysz solution. He completed his undergraduate degree in computer science and has deep experience applying machine learning methods. His PhD from UCSD focused on extracting signals from a complex medium.
Experienced clinical device development and go-to-market strategist with 15+ years of global medical device and partnership experience. Currently develops and manages our partner ecosystem.
Leads the Eysz cognitive research team. Practicing neuropsychology for over 12 years primarily in the Bay Area. She is also the head Neuropsychologist in the Epilepsy department at UCSF Benioff Children’s Hospital Oakland
Dr. Fisher is Maslah Saul MD Professor and Director of the Stanford Epilepsy Center. He had research awards from the Klingenstein Foundation, EF, CURE and NIH. He published 160 peer-reviewed articles and 4 books. He was named 1996-2016 in Best Doctors in America. He received the Ambassador Award from the International League Against Epilepsy, the 2005 AES Service Award and the 2006 Annual Clinical Research Award.
Dr. Blumenfeld's clinical and research work focuses on epilepsy, cognition and brain imaging. He directs Yale's Clinical Neuroscience Imaging Center (CNIC), a new multi-disciplinary core facility for innovative study and treatment of brain disorders. Teaching activities include a textbook titled Neuroanatomy Through Clinical Cases, Sinauer Assoc., Publ. 2002, 2010.
Dr. Milford has over 15 years experience in developing high technology instrumentation. He was CTO of Eyefluence, which was developing the next generation eye-tracking wearable technology, up until October 2016, when purchased by Google. He continued to develop eye interaction and eye tracking for augmented reality (AR) and virtual reality (VR) headsets. He now serves as the President of Parallel Rules consulting firm.
Steve brings 30+ years of leadership and strategy experience in the Medical Device industry. He has held a variety of leadership roles in various cross functional areas. Most recently, he is serving as the President and Chairman of Nuvolase Inc., which has developed the gold standard for Onychomycosis. Under his leadership, the company has grown in revenues, remained debt-free, and has expanded into new markets.
Randy leverages his corporate experience, where he has held roles as a corporate and business development executive and as general counsel, to help nurture over 25 startups in healthcare from funding, to serving as a board of director to corporate and business development and strategic initiatives. He currently services as a Partner for Ventac Partners and a Senior Advisor for Mesa Partners. He is also a parent of a child with epilepsy.